Version 2024

2024 ICD-10-CM Diagnosis Code Z19

Hormone sensitivity malignancy status

ICD-10-CM Code:
Z19
ICD-10 Code for:
Hormone sensitivity malignancy status
Is Billable?
Not Valid for Submission
Code Navigator:

Code Classification

  • Factors influencing health status and contact with health services
    (Z00–Z99)
    • Hormone sensitivity malignancy status
      (Z19)
      • Hormone sensitivity malignancy status
        (Z19)

Z19 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of hormone sensitivity malignancy status. The code is not specific and is NOT valid for the year 2024 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Specific Coding Applicable to Hormone sensitivity malignancy status

Non-specific codes like Z19 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10-CM codes with a higher level of specificity when coding for hormone sensitivity malignancy status:

  • Use Z19.1 for Hormone sensitive malignancy status - BILLABLE CODE

  • Use Z19.2 for Hormone resistant malignancy status - BILLABLE CODE

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Code First

Code First
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists, there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
  • malignant neoplasm - see Table of Neoplasms, by site, malignant

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018